Jack Zhang Net Worth

The estimated Net Worth of Jack Y.Luo Mary Z. Zhang is at least $135 Milion dollars as of 10 June 2024. Mr. Zhang owns over 100,000 units of Amphastar Pharmaceuticals Inc stock worth over $114,187,279 and over the last 10 years he sold AMPH stock worth over $14,540,770. In addition, he makes $5,969,740 as President, Chief Executive Officer, Chief Scientific Officer oraz Director at Amphastar Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Zhang AMPH stock SEC Form 4 insiders trading

Jack has made over 22 trades of the Amphastar Pharmaceuticals Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 100,000 units of AMPH stock worth $1,469,000 on 10 June 2024.

The largest trade he's ever made was exercising 1,032,976 units of Amphastar Pharmaceuticals Inc stock on 15 March 2024 worth over $12,870,881. On average, Jack trades about 152,152 units every 80 days since 2015. As of 10 June 2024 he still owns at least 2,533,554 units of Amphastar Pharmaceuticals Inc stock.

You can see the complete history of Mr. Zhang stock trades at the bottom of the page.

Jack Zhang biography

Jack Yongfeng Zhang serves as President, Chief Executive Officer, Chief Scientific Officer, Director of the Company. Dr. Zhang co-founded our company in 1996 and has served as our Chief Executive Officer and a member of our board of directors since our inception and as our President from 1996 until June 2013. Dr. Zhang has also served as our Chief Scientific Officer since 2005. Dr. Zhang co-founded APCL, a full service chemical analytical laboratory, in May 1989, where he held the position of President until October 2002. Dr. Zhang is named as the inventor on several U.S. and foreign patents. He received a Ph.D. in chemistry from the State University of New York at Stony Brook and was a Post Doctoral Research Associate at the California Institute of Technology.

What is the salary of Jack Zhang?

As the President, Chief Executive Officer, Chief Scientific Officer oraz Director of Amphastar Pharmaceuticals Inc, the total compensation of Jack Zhang at Amphastar Pharmaceuticals Inc is $5,969,740. There are no executives at Amphastar Pharmaceuticals Inc getting paid more.

How old is Jack Zhang?

Jack Zhang is 73, he's been the President, Chief Executive Officer, Chief Scientific Officer oraz Director of Amphastar Pharmaceuticals Inc since 2020. There are 4 older and 12 younger executives at Amphastar Pharmaceuticals Inc. The oldest executive at Amphastar Pharmaceuticals Inc is Richard Koo, 79, who is the Independent Director.

Insiders trading at Amphastar Pharmaceuticals Inc

Over the last 10 years, insiders at Amphastar Pharmaceuticals Inc have traded over $72,457,295 worth of Amphastar Pharmaceuticals Inc stock and bought 66,100 units worth $921,987 . The most active insiders traders include Jack Y.Luo Mary Z. Zhang, Richard K Prins oraz William J Peters. On average, Amphastar Pharmaceuticals Inc executives and independent directors trade stock every 11 days with the average trade being worth of $1,459,051. The most recent stock trade was executed by Floyd F. Petersen on 5 September 2024, trading 3,000 units of AMPH stock currently worth $139,410.

What does Amphastar Pharmaceuticals Inc do?

amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int

Complete history of Mr. Zhang stock trades at Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc executives and stock owners

Amphastar Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Jack Zhang,
  President, Chief Executive Officer, Chief Scientific Officer, Director
• Mary Luo,
  Chief Operating Officer, Chief Scientist and Chairman of the Board
• Dr. Yongfeng Zhang,
  Co-founder, Pres, CEO, Chief Scientific Officer & Director
• William Peters,
  Chief Financial Officer, Senior Vice President, Treasurer and President of International Medication Systems, Limited
• Dr. Ziping Luo,
  Chairman, Chief Scientist & COO
• Rong Zhou,
  Executive Vice President - Production Center and President of Armstrong Pharmaceuticals, Inc.
• William J. Peters M.B.A.,
  CFO, Treasurer & Exec. VP of Fin.
• Rong Zhou,
  Exec. VP of Production Center
• Jacob Liawatidewi M.B.A.,
  Exec. VP of Corp. Admin. Center, Sales & Marketing and Corp. Sec.
• Diane Gerst,
  Director
• Richard Prins,
  Lead Independent Director
• Richard Koo,
  Independent Director
• Howard Lee,
  Independent Director
• Michael Zasloff,
  Independent Director
• Floyd Petersen,
  Independent Director
• Jacob Liawatidewi,
  Senior Vice President of Sales and Marketing, Corporate Administration Center, Corporate Secretary
• Peter Langosh,
  VP of Operational Improvement and VP of Internal Audit
• Tony Marrs,
  Sr. VP of Regulatory Affairs and Clinical Operations
• Dan Dischner,
  VP of Corp. Communications
• Stephen B. Shohet,
  Director
• Gayle Deflin,
  
• Physics & Chemistry Laborat...,
  10% owner
• Mary Z.Zhang Jack Y. Luo,
  COO,Chief Scientist & ChairmanCEO & Chief Scientific Officer
• Jason B. Shandell,
  President and General Counsel
• Marilyn J. Purchase,
  Corp. Exec. VP of Operations
• David Maris,
  Director
• Jack Y.Luo Mary Z.Applied P...,
  CEO & Chief Scientific OfficerCOO,Chief Scientist & Chairman
• Yakob Liawatidewi,
  EVP CORP ADMIN CENTER